Hotta, R., Ohira, M., Matsuura, T., Muraoka, I., Tryphonopoulos, P., Fan, J., . . . Nishida, S. (2016). CD52-Negative NK cells are abundant in the liver and less susceptible to alemtuzumab treatment. Public Library of Science.
Čikaški stil citiranja (17. izdanje)Hotta, R., et al. CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment. Public Library of Science, 2016.
MLA način citiranja (9. izdanje)Hotta, R., et al. CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment. Public Library of Science, 2016.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.